About Phenomenex
Phenomenex is a company based in Torrance (United States) founded in 1982 was acquired by Danaher in October 2016. The company has 58 employees as of April 02, 2024. Phenomenex offers products and services including Biozen LC Columns, Zebron GC Columns, and Strata-X PRO SPE Products. Phenomenex operates in a competitive market with competitors including ChromaTan, Reach Separations, Sepax Technologies, Knauer and BIA Separations, among others.
- Headquarter Torrance, United States
- Employees 58 as on 02 Apr, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Phenomenex India Private Limited
- Date of Incorporation 03 Dec, 2010
- Jurisdiction Hyderabad, Telangana, India
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Phenomenex
Phenomenex offers a comprehensive portfolio of products and services, including Biozen LC Columns, Zebron GC Columns, and Strata-X PRO SPE Products.
Columns for biologics analysis in separation processes
Low bleed separations for gas chromatography applications
Tools to reduce sample clean-up time efficiently
People of Phenomenex
Unlock access to complete
Sales and Marketing
63 people
Software Development Team
38 people
Account Team
11 people
Leadership Team
9 people
Human Resources and Administration
7 people
Product Management Team
6 people
Global Team
5 people
Finance and Accounting
4 people
Unlock access to complete
Funding Insights of Phenomenex
Detailed funding history for Phenomenex
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Phenomenex
Phenomenex has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Danaher.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Dental equipment and medical instruments are manufactured for therapeutic areas.
|
Locked | Locked | Locked |
Investor details for Phenomenex
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Phenomenex
Investment portfolio details for Phenomenex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Phenomenex
Detailed financials for Phenomenex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Phenomenex Comparisons
Peer comparison for Phenomenex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Phenomenex
Phenomenex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChromaTan, Reach Separations, Sepax Technologies, Knauer and BIA Separations, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Continuous countercurrent tangential chromatography separation technology is developed.
|
|
| Locked | Locked | Locked |
Small molecule analysis and purification services are provided using chromatography.
|
|
| Locked | Locked | Locked |
Solutions for chromatographic biomolecular separation are developed and provided.
|
|
| Locked | Locked | Locked |
Provides liquid chromatography solutions
|
|
| Locked | Locked | Locked |
Monolithic chromatographic columns are developed using Convective Interaction Media technology.
|
|
| Locked | Locked | Locked |
Biomolecular separation technologies are enabled for bioprocessing applications.
|
Detailed competitors of Phenomenex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Phenomenex
Complete news archive for Phenomenex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Phenomenex
Phenomenex was founded in 1982.
Phenomenex is headquartered in Torrance, United States. It is registered at Torrance, California, United States.
As of Apr 02, 2024, the latest employee count at Phenomenex is 58.
Annual revenue of Phenomenex is $12.31M as on Mar 31, 2023.
Phenomenex specializes in chromatography solutions for research applications. Their product range covers the whole spectrum of chromatography applications including HPLCUPLC (reverse phase, normal phase, chiral, size exclusion, HILIC, Ion-exchange and Ion-exclusion), GC (GC columns, Inlet liners and other accessories), SPE, protein precipitation, phospholipid removal, filtration, SLE, BGR, SFC, and preparative columns. The company also manufactures bulk media, oligonucleotides, and reagents for amino acid analysis.
Phenomenex's top competitors include ChromaTan, Sepragen and Sepax Technologies.
Phenomenex offers Biozen LC Columns, Zebron GC Columns, and Strata-X PRO SPE Products.
Phenomenex has 1 investor. Key investors include Danaher.